



- Công bố khoa học và công nghệ Việt Nam
Tiêu hoá và gan mật học
Đào Việt Hằng(1), Trần Thị Thu Trang, Lưu Thị Minh Huế
Liên quan giữa nồng độ pepsin trong nước bọt với kết quả nội soi và mô bệnh học ở bệnh nhân có triệu chứng trào ngược dạ dày thực quản
Tạp chí Nghiên cứu y học (Đại học Y Hà Nội)
2021
04
109-118
2354-080X
TTKHCNQG, CVv 251
- [1] El-Serag HB. (), Epidemiology of nonerosive reflux disease.,Digestion. 2008;78 Suppl 1:6-10.
- [2] Hershcovici T, Fass R. (), Nonerosive Reflux Disease (NERD) - An Up-date.,J Neurogastroenterol Motil. 2010;16(1):8-21.
- [3] Zhou LY, Wang Y, Lu JJ, et al. (), Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology.,Journal of digestive diseases. 2014;15(5):230-238.
- [4] Ismail-Beigi F, Horton PF, Pope CE, 2nd (), Histological consequences of gastroesophageal reflux in man.,Gastroenterology. 1970;58(2):163-174.
- [5] Li YW, Sifrim D, Xie C, Chen M, Xiao YL. (), Relationship Between Salivary Pepsin Concentration and Esophageal Mucosal Integrity in Patients With Gastroesophageal Reflux Disease,J Neurogastroenterol Motil. 2017;23(4):517-525.
- [6] Rasijeff AMP, Jackson W, Burke JM, Dettmar P (), PWE-172 Does salivary pepsin measurement change diagnostic outcome in patients investigated by 24h ph monitoring?,Gut. 2015;64:A287.283-A288.
- [7] Iluyomade A, Olowoyeye A, Fadahunsi O, et al. (), Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.,Dis Esophagus. 2017;30(3):1-9.
- [8] Mohamed H, Khodeer S, Shaheen W. (), Study of pepsin level in saliva as a noninvasive marker for diagnosis of gastroesophageal reflux disease.,2020;33(1):94-100.
- [9] Hayat JO, Gabieta-Somnez S, Yazaki E, et al. (), Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease,Gut. 2015;64(3):373-380.
- [10] Du X, Wang F, Hu Z, et al (), The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study f-rom China,BMC gastroenterology. 2017;17(1):107.
- [11] Strachan T, Melter J, Barabasová A, et al. (), Pepsin in secretion f-rom the upper respiratory tract as a marker of extraesophageal reflux in children.,Cesko-Slovenska Pediatrie. 2017;72:176-181.
- [12] (2015), Peptest for diagnosing gastroesophageal reflux,
- [13] Fiocca R, Mastracci L, Riddell R, et al. (), Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project,Hum Pathol. 2010;41(2):223-231.
- [14] Sami SS, Ragunath K. (), The Los Angeles Classification of Gastroesophageal Reflux Disease,Video Journal and Encyclopedia of GI Endoscopy. 2013;1(1):103-104.
- [15] Ocak E, Kubat G, Yorulmaz I. (), Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux.,Balkan Med J. 2015;32(1):46-50.
- [16] Zhang M, Pandolfino JE, Zhou X, et al. (), Assessing different diagnostic tests for gastroesophageal reflux disease: a systematic review and network meta-analysis.,Therapeutic advances in gastroenterology. 2019;12:1756284819890537.
- [17] Wang YF, Yang CQ, Chen YX, et al. (), Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease,Journal of digestive diseases. 2019;20(6):278-287.
- [18] Wang YJ, Lang XQ, Wu D, et al (), Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Diseaserelated Disorders,J Neurogastroenterol Motil. 2020;26(1):74-84.
- [19] Race C, Chowdry J, Russell JM, Corfe BM, Riley SA (), Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.,Alimentary pharmacology & therapeutics. 2019;49(9):1173-1180.
- [20] Zentilin P, Savarino V, Mastracci L, et al. (), Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group,The American journal of gastroenterology. 2005;100(10):2299-2306
- [21] Dent J. (), Microscopic esophageal mucosal injury in nonerosive reflux disease.,Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2007;5(1):4-16.
- [22] N E Schindlbeck, A G Klauser, G Berghammer, W Londong, S A MullerLissner (), Three year follow up of patients with gastrooesophageal reflux disease,Gut. 1992;33:1016-1019.
- [23] Gyawali CP, Kahrilas PJ, Savarino E, et al. (), Modern diagnosis of GERD: the Lyon Consensus.,Gut. 2018;67(7):1351-1362
- [24] Min YW, Lim SW, Lee JH, et al (), Prevalence of Extraesophageal Symptoms in Patients With Gastroesophageal Reflux Disease: A Multicenter Questionnaire-based Study in Korea,J Neurogastroenterol Motil. 2014;20(1):87-93.
- [25] Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. (), The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.,The American journal of gastroenterology. 2006;101(8):1900-1920; quiz 1943.